Product Stewardship Notes
DuPont Titanium Technologies is committed to excellence in product stewardship. Our Product Stewardship Program promotes adherence to the principles of safety, health and environmental protection throughout the life cycle of Ti-Pure®
titanium dioxide (TiO2
) products. DuPont shares its learnings, recommendations and innovations in TiO2
product stewardship technology with our customers to assist in their own product stewardship efforts.
Medical Applications Policy
The information in this section applies to those customers who supply or use Ti-Pure®
in medical articles, devices or applications. You may recall the "DuPont Policy Regarding Medical Applications of DuPont Materials" stated below that has been in effect since January 1, 1993.
- DuPont will not supply materials for use in medical articles or applications intended for permanent implantation in the human body or in permanent contact with internal body fluids or tissues.
- Sales of materials for use in medical articles or applications intended for brief or temporary implantation in the human body, or in brief or temporary contact with internal body fluids or tissues,
- DuPont does not provide samples for research, technical information, or technical support for any of the medical applications mentioned above.
Copies of DuPont's Medical Policy and Caution Statements may be obtained by calling Mr. Brian Coleman at 302-999-2122, USA. The continued adherence by customers to this Policy is requested.
FDA and NSF Status for Ti-Pure® TiO2 in Paper Applications
and RPD-2 are acceptable for FDA indirect food use as colorants under 21 CFR 176.170 and 21 CFR 176.180, without restriction on Conditions of Use (compliant for Conditions A-H) or Food Type (compliant for Food Types I - IX). In addition, these products may be used in contact with all types of food (I - IX) as described in Table 1 of 21 CFR 176.170, under microwave susceptor conditions.
DuPont customers are urged to review their TiO2 product uses and current handling practices for consistency with the above recommendations.
Updated: March 2007